The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Biopharmaceutical Fermentation Systems Market Research Report 2024

Global Biopharmaceutical Fermentation Systems Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1431837

No of Pages : 89

Synopsis

Biopharmaceutical fermentation system refers to a biopharmaceutical equipment, it can be divided into fermenters, bioprocess analyzers, process monitoring devices, culture & media preparation.

The global Biopharmaceutical Fermentation Systems market was valued at US$ 1643 million in 2023 and is anticipated to reach US$ 2265.4 million by 2030, witnessing a CAGR of 4.7% during the forecast period 2024-2030.

In terms of application, the recombinant proteins segment held a major market share in 2017. High reliance on microbial systems for recombinant protein production contributed toward the leading share of the segment. Increase in investment in research activities and introduction of new protein therapeutics have significantly contributed to the development of recombinant therapeutic antibodies and proteins.

This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical Fermentation Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical Fermentation Systems.

Report Scope

The Biopharmaceutical Fermentation Systems market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biopharmaceutical Fermentation Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Biopharmaceutical Fermentation Systems companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • GE Healthcare
  • Thermo Fisher Scientific
  • Danaher
  • Sartorius StedimBiotech
  • Merck
  • Eppendorf
  • Roche
  • Nova Biomedicals
  • Lonza
  • Becton
  • Dickinson and Company
  • GEA

Segment by Type

  • Fermenters
  • Bioprocess Analyzers
  • Process Monitoring Devices
  • Culture & Media Preparation
  • Culture Media, Buffers & Inducers
  • Others

Segment by Application

  • Biopharmaceutical Companies
  • Contract Manufacturing Organizations
  • Contract Research Organizations
  • Academic Research Institutes
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biopharmaceutical Fermentation Systems companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceutical Fermentation Systems Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Fermenters
1.2.3 Bioprocess Analyzers
1.2.4 Process Monitoring Devices
1.2.5 Culture & Media Preparation
1.2.6 Culture Media, Buffers & Inducers
1.2.7 Others
1.3 Market by Application
1.3.1 Global Biopharmaceutical Fermentation Systems Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biopharmaceutical Companies
1.3.3 Contract Manufacturing Organizations
1.3.4 Contract Research Organizations
1.3.5 Academic Research Institutes
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceutical Fermentation Systems Market Perspective (2019-2030)
2.2 Biopharmaceutical Fermentation Systems Growth Trends by Region
2.2.1 Global Biopharmaceutical Fermentation Systems Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biopharmaceutical Fermentation Systems Historic Market Size by Region (2019-2024)
2.2.3 Biopharmaceutical Fermentation Systems Forecasted Market Size by Region (2025-2030)
2.3 Biopharmaceutical Fermentation Systems Market Dynamics
2.3.1 Biopharmaceutical Fermentation Systems Industry Trends
2.3.2 Biopharmaceutical Fermentation Systems Market Drivers
2.3.3 Biopharmaceutical Fermentation Systems Market Challenges
2.3.4 Biopharmaceutical Fermentation Systems Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceutical Fermentation Systems Players by Revenue
3.1.1 Global Top Biopharmaceutical Fermentation Systems Players by Revenue (2019-2024)
3.1.2 Global Biopharmaceutical Fermentation Systems Revenue Market Share by Players (2019-2024)
3.2 Global Biopharmaceutical Fermentation Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biopharmaceutical Fermentation Systems Revenue
3.4 Global Biopharmaceutical Fermentation Systems Market Concentration Ratio
3.4.1 Global Biopharmaceutical Fermentation Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical Fermentation Systems Revenue in 2023
3.5 Biopharmaceutical Fermentation Systems Key Players Head office and Area Served
3.6 Key Players Biopharmaceutical Fermentation Systems Product Solution and Service
3.7 Date of Enter into Biopharmaceutical Fermentation Systems Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceutical Fermentation Systems Breakdown Data by Type
4.1 Global Biopharmaceutical Fermentation Systems Historic Market Size by Type (2019-2024)
4.2 Global Biopharmaceutical Fermentation Systems Forecasted Market Size by Type (2025-2030)
5 Biopharmaceutical Fermentation Systems Breakdown Data by Application
5.1 Global Biopharmaceutical Fermentation Systems Historic Market Size by Application (2019-2024)
5.2 Global Biopharmaceutical Fermentation Systems Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Biopharmaceutical Fermentation Systems Market Size (2019-2030)
6.2 North America Biopharmaceutical Fermentation Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Biopharmaceutical Fermentation Systems Market Size by Country (2019-2024)
6.4 North America Biopharmaceutical Fermentation Systems Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biopharmaceutical Fermentation Systems Market Size (2019-2030)
7.2 Europe Biopharmaceutical Fermentation Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Biopharmaceutical Fermentation Systems Market Size by Country (2019-2024)
7.4 Europe Biopharmaceutical Fermentation Systems Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceutical Fermentation Systems Market Size (2019-2030)
8.2 Asia-Pacific Biopharmaceutical Fermentation Systems Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Biopharmaceutical Fermentation Systems Market Size by Region (2019-2024)
8.4 Asia-Pacific Biopharmaceutical Fermentation Systems Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biopharmaceutical Fermentation Systems Market Size (2019-2030)
9.2 Latin America Biopharmaceutical Fermentation Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Biopharmaceutical Fermentation Systems Market Size by Country (2019-2024)
9.4 Latin America Biopharmaceutical Fermentation Systems Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (2019-2030)
10.2 Middle East & Africa Biopharmaceutical Fermentation Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Biopharmaceutical Fermentation Systems Market Size by Country (2019-2024)
10.4 Middle East & Africa Biopharmaceutical Fermentation Systems Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GE Healthcare
11.1.1 GE Healthcare Company Detail
11.1.2 GE Healthcare Business Overview
11.1.3 GE Healthcare Biopharmaceutical Fermentation Systems Introduction
11.1.4 GE Healthcare Revenue in Biopharmaceutical Fermentation Systems Business (2019-2024)
11.1.5 GE Healthcare Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Biopharmaceutical Fermentation Systems Introduction
11.2.4 Thermo Fisher Scientific Revenue in Biopharmaceutical Fermentation Systems Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Danaher
11.3.1 Danaher Company Detail
11.3.2 Danaher Business Overview
11.3.3 Danaher Biopharmaceutical Fermentation Systems Introduction
11.3.4 Danaher Revenue in Biopharmaceutical Fermentation Systems Business (2019-2024)
11.3.5 Danaher Recent Development
11.4 Sartorius StedimBiotech
11.4.1 Sartorius StedimBiotech Company Detail
11.4.2 Sartorius StedimBiotech Business Overview
11.4.3 Sartorius StedimBiotech Biopharmaceutical Fermentation Systems Introduction
11.4.4 Sartorius StedimBiotech Revenue in Biopharmaceutical Fermentation Systems Business (2019-2024)
11.4.5 Sartorius StedimBiotech Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Biopharmaceutical Fermentation Systems Introduction
11.5.4 Merck Revenue in Biopharmaceutical Fermentation Systems Business (2019-2024)
11.5.5 Merck Recent Development
11.6 Eppendorf
11.6.1 Eppendorf Company Detail
11.6.2 Eppendorf Business Overview
11.6.3 Eppendorf Biopharmaceutical Fermentation Systems Introduction
11.6.4 Eppendorf Revenue in Biopharmaceutical Fermentation Systems Business (2019-2024)
11.6.5 Eppendorf Recent Development
11.7 Roche
11.7.1 Roche Company Detail
11.7.2 Roche Business Overview
11.7.3 Roche Biopharmaceutical Fermentation Systems Introduction
11.7.4 Roche Revenue in Biopharmaceutical Fermentation Systems Business (2019-2024)
11.7.5 Roche Recent Development
11.8 Nova Biomedicals
11.8.1 Nova Biomedicals Company Detail
11.8.2 Nova Biomedicals Business Overview
11.8.3 Nova Biomedicals Biopharmaceutical Fermentation Systems Introduction
11.8.4 Nova Biomedicals Revenue in Biopharmaceutical Fermentation Systems Business (2019-2024)
11.8.5 Nova Biomedicals Recent Development
11.9 Lonza
11.9.1 Lonza Company Detail
11.9.2 Lonza Business Overview
11.9.3 Lonza Biopharmaceutical Fermentation Systems Introduction
11.9.4 Lonza Revenue in Biopharmaceutical Fermentation Systems Business (2019-2024)
11.9.5 Lonza Recent Development
11.10 Becton
11.10.1 Becton Company Detail
11.10.2 Becton Business Overview
11.10.3 Becton Biopharmaceutical Fermentation Systems Introduction
11.10.4 Becton Revenue in Biopharmaceutical Fermentation Systems Business (2019-2024)
11.10.5 Becton Recent Development
11.11 Dickinson and Company
11.11.1 Dickinson and Company Company Detail
11.11.2 Dickinson and Company Business Overview
11.11.3 Dickinson and Company Biopharmaceutical Fermentation Systems Introduction
11.11.4 Dickinson and Company Revenue in Biopharmaceutical Fermentation Systems Business (2019-2024)
11.11.5 Dickinson and Company Recent Development
11.12 GEA
11.12.1 GEA Company Detail
11.12.2 GEA Business Overview
11.12.3 GEA Biopharmaceutical Fermentation Systems Introduction
11.12.4 GEA Revenue in Biopharmaceutical Fermentation Systems Business (2019-2024)
11.12.5 GEA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’